Obesity is a driving factor in the onset of metabolic disorders. This study aims to investigate
the effects of the myricetin derivative-rich fraction (MD) from Syzygium malaccense leaf …

Results: Those treated with orlistat showed greater weight loss (–9.4±2.3 vs.–4.9±1.3 kg, p<
0.05) and decrease of fat mass (–5.4±3.0 vs.–3.5±0.7 kg, p< 0.05) than those treated with …

Context Polycystic ovary syndrome (PCOS) is a heterogeneous condition affecting women of
reproductive age and is associated with increased body weight. Objective To review the …

Aim This meta‐analysis was conducted to compare the effect and safety of oral
contraceptive pills (OCP) plus orlistat with OCP alone in clinical, hormonal, and lipid …

Background Irisin is an adipo-myokine with potential implications in metabolic disorders
such as polycystic ovary syndrome (PCOS). Despite of a strong evidence showing increased …

Objective Serotonin reuptake inhibitors cause weight gain, leading to drug discontinuation,
relapse, and worsening of symptoms. This study aims to investigates the effect of metformin …

Polycystic ovary syndrome (PCOS) is the commonest endocrine disorder in women of
reproductive age. Obesity is frequently present in these patients and plays a key role in the …

Methods The present study was carried out in the clinic of Infertility and Reproductive Health
Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran. Thirty-two …

Objective: To compare the efficacy of Metformin and Orlistat in improving ovulation and
reducing body mass index in anovulatory, overweight and obese women with polycystic …